Skip to main content

Table 2 Cox univariate and multivariate model for heart failure rehospitalization within 1 year in the heart failure with reduced ejection fraction group

From: Reinforcement of pimobendan with guideline-directed medical therapy may reduce the rehospitalization rates in patients with heart failure: retrospective cohort study

Variable

univariate

multivariate

Hazard ratio

(95% CI)

p-value

Hazard ratio

(95% CI)

p-value

Male

0.95 (0.46–1.97)

0.883

1.15 (0.54–2.47)

0.718

Age

1.02 (0.99–1.04)

0.274

1.01 (0.98–1.04)

0.671

β-blocker or MRA reinforcement

0.47 (0.22–0.99)

0.048

0.54 (0.24–1.21)

0.134

Albumin (g/dL) at discharge

0.84 (0.41–1.71)

0.632

  

eGFR (mL/min/1.73m2) at discharge

0.98 (0.96-1.00)

0.116

0.99 (0.97–1.01)

0.134

Hemoglobin (g/dL) at discharge

0.92 (0.77–1.10)

0.354

  
  1. Abbreviations: eGFR, estimated glomerular filtration rate; MRA, mineralocorticoid receptor antagonist